High-Throughput Screening Platform Identifies Small Molecules That Prevent Sequestration ofPlasmodium falciparum–Infected Erythrocytes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-Throughput Screening Platform Identifies Small Molecules That Prevent Sequestration ofPlasmodium falciparum–Infected Erythrocytes
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 211, Issue 7, Pages 1134-1143
Publisher
Oxford University Press (OUP)
Online
2014-10-30
DOI
10.1093/infdis/jiu589
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Parasite Burden and Severity of Malaria in Tanzanian Children
- (2014) Bronner P. Gonçalves et al. NEW ENGLAND JOURNAL OF MEDICINE
- Malaria's deadly grip: cytoadhesion ofPlasmodium falciparum-infected erythrocytes
- (2013) Joseph D. Smith et al. CELLULAR MICROBIOLOGY
- Antibodies to Escherichia coli-Expressed C-Terminal Domains of Plasmodium falciparum Variant Surface Antigen 2-Chondroitin Sulfate A (VAR2CSA) Inhibit Binding of CSA-Adherent Parasites to Placental Tissue
- (2013) Tracy Saveria et al. INFECTION AND IMMUNITY
- Structure-Function-Immunogenicity Studies of PfEMP1 Domain DBL2βPF11_0521, a Malaria Parasite Ligand for ICAM-1
- (2013) Justin Gullingsrud et al. PLoS One
- Multilaboratory Approach to Preclinical Evaluation of Vaccine Immunogens for Placental Malaria
- (2012) Michal Fried et al. INFECTION AND IMMUNITY
- A Plasma Survey Using 38 PfEMP1 Domains Reveals Frequent Recognition of the Plasmodium falciparum Antigen VAR2CSA among Young Tanzanian Children
- (2012) Andrew V. Oleinikov et al. PLoS One
- Investigating the Host Binding Signature on the Plasmodium falciparum PfEMP1 Protein Family
- (2011) Joel H. Janes et al. PLoS Pathogens
- Strain-Transcendent Immune Response to Recombinant Var2CSA DBL5-ε Domain Block P. falciparum Adhesion to Placenta-Derived BeWo Cells under Flow Conditions
- (2010) Pablo Fernandez et al. PLoS One
- Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA
- (2010) A. Srivastava et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Can any lessons be learned from the ambiguous glycan binding of PfEMP1 domains?
- (2010) Madeleine Dahlbäck et al. TRENDS IN PARASITOLOGY
- High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women
- (2010) Pamela A. Magistrado et al. VACCINE
- Induction of Adhesion-Inhibitory Antibodies against Placental Plasmodium falciparum Parasites by Using Single Domains of VAR2CSA
- (2009) M. A. Nielsen et al. INFECTION AND IMMUNITY
- Continued cytoadherence of Plasmodium falciparum infected red blood cells after antimalarial treatment
- (2009) Katie R. Hughes et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Human monoclonal IgG selection ofPlasmodium falciparumfor the expression of placental malaria-specific variant surface antigens
- (2009) J. SOERLI et al. PARASITE IMMUNOLOGY
- High Throughput Functional Assays of the Variant Antigen PfEMP1 Reveal a Single Domain in the 3D7 Plasmodium falciparum Genome that Binds ICAM1 with High Affinity and Is Targeted by Naturally Acquired Neutralizing Antibodies
- (2009) Andrew V. Oleinikov et al. PLoS Pathogens
- VAR2CSA Domains Expressed inEscherichia coliInduce Cross‐Reactive Antibodies to Native Protein
- (2008) Andrew V. Oleinikov et al. JOURNAL OF INFECTIOUS DISEASES
- A highly sensitive, PCR-based method for the detection of Plasmodium falciparum clones in microtiter plates
- (2008) Steven P Maher et al. MALARIA JOURNAL
- Clinical significance of sequestration in adults with severe malaria
- (2008) A.M. Dondorp TRANSFUSION CLINIQUE ET BIOLOGIQUE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started